rivastigmine has been researched along with Sensitivity and Specificity in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (81.82) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, SH; Hsieh, YH; Lin, PC; Yang, YH; Yeh, HH | 1 |
Arumugam, K; Averineni, R; Chamallamudi, MR; Ganesan, S; Gilibili, RR; Kar, SS; Mullangi, R; Shavi, G; Udupa, N | 1 |
Meng, X; Somogyi, M; Weintraub, D | 1 |
Frigola, R; Pommier, F | 1 |
Barkhof, F; Bastos Leite, AJ; Lycklama, G; Scheltens, P; van Straaten, EC | 1 |
Chappuis, A; Dattler, A; Enz, A | 1 |
Abramowski, D; De Deyn, PP; Staufenbiel, M; Van Dam, D | 1 |
Carducci, CN; Kenndler, E; Lucangioli, SE; Masrian, E; Scioscia, SL; Tripodi, V | 1 |
Beijnen, JH; Frankfort, SV; Ouwehand, M; Rosing, H; Tulner, LR; van Maanen, MJ | 1 |
Baliga, A; Bhatt, J; Kambli, S; Nigam, S; Parekh, H; Patel, M; Saxena, A; Shah, B; Subbaiah, G; Yadav, G | 1 |
Klein, C; Rabey, JM; Werber, AE | 1 |
11 other study(ies) available for rivastigmine and Sensitivity and Specificity
Article | Year |
---|---|
Simultaneous determination of galantamine, rivastigmine and NAP 226-90 in plasma by MEKC and its application in Alzheimer's disease.
Topics: Adult; Alzheimer Disease; Benzylamines; Buffers; Cholinesterase Inhibitors; Chromatography, Micellar Electrokinetic Capillary; Drug Monitoring; Galantamine; Humans; Male; Phenethylamines; Phenols; Phenylcarbamates; Phosphoric Acids; Reproducibility of Results; Rivastigmine; Sensitivity and Specificity; Solvents; Surface-Active Agents | 2009 |
Development and validation of a HPLC method for quantification of rivastigmine in rat urine and identification of a novel metabolite in urine by LC-MS/MS.
Topics: Animals; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Drug Stability; Least-Squares Analysis; Phenylcarbamates; Rats; Reproducibility of Results; Rivastigmine; Sensitivity and Specificity; Tandem Mass Spectrometry | 2011 |
Rivastigmine in Alzheimer's disease and Parkinson's disease dementia: an ADAS-cog factor analysis.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Databases, Factual; Humans; Neuropsychological Tests; Parkinson Disease; Phenylcarbamates; Retrospective Studies; Rivastigmine; Sensitivity and Specificity; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2011 |
Quantitative determination of rivastigmine and its major metabolite in human plasma by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry.
Topics: Calibration; Carbamates; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Humans; Phenylcarbamates; Reference Standards; Reproducibility of Results; Rivastigmine; Sensitivity and Specificity | 2003 |
Thalamic lesions in vascular dementia: low sensitivity of fluid-attenuated inversion recovery (FLAIR) imaging.
Topics: Aged; Aged, 80 and over; Carbamates; Clinical Trials, Phase III as Topic; Dementia, Vascular; Humans; Magnetic Resonance Imaging; Middle Aged; Multicenter Studies as Topic; Phenylcarbamates; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Rivastigmine; Sensitivity and Specificity; Single-Blind Method; Thalamus | 2004 |
A simple, rapid and sensitive method for simultaneous determination of rivastigmine and its major metabolite NAP 226-90 in rat brain and plasma by reversed-phase liquid chromatography coupled to electrospray ionization mass spectrometry.
Topics: Animals; Benzylamines; Cholinesterase Inhibitors; Chromatography, Liquid; Phenethylamines; Phenols; Phenylcarbamates; Rats; Reproducibility of Results; Rivastigmine; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2004 |
Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cholinesterase Inhibitors; Cognition; Disease Models, Animal; Donepezil; Dose-Response Relationship, Drug; Galantamine; Humans; Indans; Male; Memantine; Mice; Mice, Mutant Strains; Phenylcarbamates; Piperidines; Rivastigmine; Sensitivity and Specificity | 2005 |
Enantioselective separation of rivastigmine by capillary electrophoresis with cyclodextrines.
Topics: beta-Cyclodextrins; Electrophoresis, Capillary; Phenylcarbamates; Rivastigmine; Sensitivity and Specificity; Stereoisomerism | 2005 |
A simple and sensitive assay for the quantitative analysis of rivastigmine and its metabolite NAP 226-90 in human EDTA plasma using coupled liquid chromatography and tandem mass spectrometry.
Topics: Administration, Oral; Benzylamines; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Edetic Acid; Humans; Phenethylamines; Phenols; Phenylcarbamates; Reproducibility of Results; Rivastigmine; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2006 |
A rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the estimation of rivastigmine in human plasma.
Topics: Administration, Oral; Cholinesterase Inhibitors; Humans; Male; Phenylcarbamates; Reference Standards; Reproducibility of Results; Rivastigmine; Sensitivity and Specificity; Tandem Mass Spectrometry | 2007 |
Evaluation of cholinergic treatment in demented patients by P300 evoked related potentials.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Carbamates; Cholinesterase Inhibitors; Cognition; Donepezil; Evaluation Studies as Topic; Event-Related Potentials, P300; Female; Humans; Indans; Male; Middle Aged; Neuropsychological Tests; Phenylcarbamates; Piperidines; Reaction Time; Rivastigmine; Sensitivity and Specificity; Severity of Illness Index; Tacrine | 2001 |